Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points

Lutetium-177 prostate-specific membrane antigen (PSMA

Frontiers Developments in 177Lu-based radiopharmaceutical

Pharmaceuticals, Free Full-Text

Cancers, Free Full-Text

Lutetium-177 prostate-specific membrane antigen (PSMA

Development of 177Lu-scFvD2B as a Potential Immunotheranostic

Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T

Pharmaceuticals, Free Full-Text

Hotspots and frontiers in PSMA research for prostate cancer: a